Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-069307
Filing Date
2022-06-08
Accepted
2022-06-08 16:08:03
Documents
2
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2217755-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2217755-4_4seq1.xml 4 10243
2 EXHIBIT 24 tm2217755d4_ex24.htm EX-24 5743
  Complete submission text file 0001104659-22-069307.txt   17522
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYTODYN INC. 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address
Kelly Scott A. (Reporting) CIK: 0001703394 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 221003597